Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Pfaender

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Kidney International Reports|January 16, 2023
Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis PatientsMoritz Anft, Sarah Skrzypczyk, Michael Frahnert, et al.
Frontiers in Microbiology|April 12, 2018
Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body FluidsStephanie Pfaender, Fabian A Helfritz, Anindya Siddharta, et al.
Kidney International Reports|January 30, 2023
Immunogenicity of Bivalent Omicron BA.4/5-Adapted Vaccine in Hemodialysis PatientsMoritz Anft, Sarah Skrzypczyk, Michael Frahnert, et al.
The Journal of Infectious Diseases|October 3, 2020
Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2Toni Luise Meister, Yannick Brüggemann, Daniel Todt, et al.
Cell Biology and Toxicology|November 13, 2024
Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseasesNoha Awad, Daniel Weidinger, Lea Greune, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 27, 2021
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assayPaul Wollschläger, Daniel Todt, Nadja Gerlitz, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
The Journal of Infectious Diseases|July 30, 2020
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2Toni Luise Meister, Yannick Brüggemann, Daniel Todt, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2022
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Ricarda Rohling, et al.
Scientific Reports|November 19, 2016
Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugsAnindya Siddharta, Stephanie Pfaender, Angelina Malassa, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Kidney International Reports|January 16, 2023
Significant Fade of Neutralizing Antibodies and Stable Cellular Immunity in 4 Times COVID-19 Vaccinated Noninfected Compared to COVID-19 Convalescent and 3 Times Vaccinated Hemodialysis PatientsMoritz Anft, Sarah Skrzypczyk, Michael Frahnert, et al.
Frontiers in Microbiology|April 12, 2018
Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body FluidsStephanie Pfaender, Fabian A Helfritz, Anindya Siddharta, et al.
Kidney International Reports|January 30, 2023
Immunogenicity of Bivalent Omicron BA.4/5-Adapted Vaccine in Hemodialysis PatientsMoritz Anft, Sarah Skrzypczyk, Michael Frahnert, et al.
The Journal of Infectious Diseases|October 3, 2020
Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2Toni Luise Meister, Yannick Brüggemann, Daniel Todt, et al.
Cell Biology and Toxicology|November 13, 2024
Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseasesNoha Awad, Daniel Weidinger, Lea Greune, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 27, 2021
SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assayPaul Wollschläger, Daniel Todt, Nadja Gerlitz, et al.
Frontiers in Immunology|October 3, 2022
SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applicationsAnja Schlör, Stefan Hirschberg, Ghada Ben Amor, et al.
The Journal of Infectious Diseases|July 30, 2020
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2Toni Luise Meister, Yannick Brüggemann, Daniel Todt, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2022
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccinationSimon Faissner, Neele Heitmann, Ricarda Rohling, et al.
Scientific Reports|November 19, 2016
Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugsAnindya Siddharta, Stephanie Pfaender, Angelina Malassa, et al.
Pageof 11